Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists set to develop animal-free model of human airways
It is hoped the project will prevent experiements on or with animals.
Model could prevent animal tests for toxicity of e-cigarettes

Scientists at Aston University are developing an animal-free model of the human airways, to be used for testing the toxicity of e-cigarettes.

It is hoped that the project, announced ahead of World No Tobacco Day (31 May), will prevent experiments on or with animals, as questions are raised about the long-term effects of e-cigarettes.

In the USA, such experiments are already taking place, in which animals are exposed to vapours for weeks or months on end. After the experiment, the animals are usually killed so that their tissues can be analysed.

The UK does not currently use animals to test e-cigarettes. If a manufacturer wanted to register them as an aid to quit smoking, however, they would be required under new regulations to have them tested as medicinal products, which may increase the chance of animal testing.

Jan Creamer, president of Animal Defenders International, which is funding the study, said: “Public outcry at smoking experiments led to them being ended, therefore the public, including those who vape, would be concerned to see animal tests for an alternative smoking product.

“We are excited to be funding the development of this innovative project which will save animals and provide accurate human-based data. It will also advance the way human cell lines can be maintained which could have far-reaching effects.”

Foetal calf serum (FCS) is the standard method used by researchers as the medium to grow human cell lines. However, this has raised ethical concerns owing to its collection method.

In this novel project, researchers will use multiple cell types submerged in medium without FCS. The cells will be tested and the results compared to previous data from cells grown with FCS.

The researchers will then test these cells under a “dynamic flow system” which more accurately mimics the environment in human airways. The model will then be used to see how the cells respond to e-cigarette exposure.

Project leader Dr Laura Leslie said: “The use of foetal calf serum to grow human cells, although currently standard practice, can present scientific challenges.

“By developing an entirely animal-free model, we hope to set the standard for a completely human-relevant method for investigating the effects of e-cigarettes on the human airways, an area where there is currently a lack of information.”

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
Defra to host bluetongue webinar for vets

The Department for Environment, Food and Rural Affairs (Defra) will be hosting a webinar for veterinary professional on bluetongue on Thursday, 25 April 2024.

Topics covered will include the transmission cycle, pathology and pathogenesis, clinical signs (including signs seen in recent BTV-3 cases in the Netherlands), and control and prevention.

The session, which will take place from 6pm to 7.30pm, is part of Defra's 'Plan, Prevent and Protect' webinar series, which are hosted by policy officials, epidemiologists and veterinary professionals from Defra and the Animal and Plant Health Agency. The bluetongue session will also feature insights from experts from The Pirbright Institute.

Those attending will have the opportunity to ask questions. Places on the webinar can be booked online.